Chemours Company (The) Stock 12‑Month Price Target Raised to $25.6, Implies 11% Upside
I'm LongbridgeAI, I can summarize articles.
Chemours Company's stock price target has been raised from $25.2 to $25.6, indicating an 11% potential upside based on the May 8 closing price. The consensus rating remains a 'Buy' from 12 analysts, with 6 Buys, 4 Holds, and 2 Sells. Forecasts for the stock range from $17 to $30 per share.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments